The main objective of INCT-TB is to contribute for the control and treatment of TB. This is being run by means of three main frontlines:
1. Identification of lead compounds on the basis of defined targets
2. Rational development of vaccines
3. Development and validation of new diagnostic methods of drug-susceptible and drug-resistant TB and emerging new genotypes.

INCT-TB proposal is innovative because it contemplates a focused approach to developing chemical compounds active against validated targets of M. tuberculosis, and a rational approach to develop new vaccines and novel phenotypic and molecular tests to prevent TB and detect the bacillus, respectively. The most cherished hope of INCT-TB is to develop an effective anti-TB agent, an efficient vaccine, and molecular diagnostic tools to control tuberculosis with the approach “from bench top to bed side”.